Black Diamond Therapeutic... (BDTX)
1.41
0.03 (2.17%)
At close: Apr 10, 2025, 12:59 PM
13F Institute Ownership
Total Institutes of 89 in Black Diamond Therapeutics reduced their positions with a decrease of 25 investors compared to the previous quarter. A reduction of 811.79K shares, as total invested capital declined by $109.37M with ownership percentage dropping from 86.21% to 84.78%.
Options Activity
Institutions are holding more Puts Contracts as Calls Contracts, indicating a bearish sentiment.
Put/Call 23.931
23.93
Call Flow 2,900
4%
Put Flow 69,400
96%
Top Shareholders
| Institute | Ownership | Shares | Shares % Change | Market Value | Portfolio |
|---|---|---|---|---|---|
| T. Rowe Price Investment Manag... | 18.52% | 10.47M | -2.49% | 22.4M | 0.01% |
| Bellevue Group Ag | 15.07% | 8.52M | +0.00% | 18.23M | 0.35% |
| Vestal Point Capital, LP | 9.91% | 5.6M | +11.37% | 11.98M | 0.71% |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.